Vertex Newswire

Comprehensive Real-Time News Feed for Vertex.

Results 1 - 20 of 338 in Vertex

  1. Nasdaq 100 Movers: GRMN, REGNRead the original story w/Photo

    10 hrs ago | Forbes.com

    ... armin is showing a gain of 17.4% looking at the year to date performance. Two other components making moves today are Vertex Pharmaceuticals (VRTX), trading down 3.4%, and Amgen (AMGN), trading up 5.5% on the day.

    Comment?

  2. Vertex Pharmaceuticals Incorporated Reports Second Quarter 2014...Read the original story

    12 hrs ago | BioSpace

    Vertex Pharmaceuticals Incorporated today reported consolidated financial results for the quarter ended June 30, 2014.

    Comment?

  3. Vertex Energy, Inc. Begins Due Diligence Process in Connection With...Read the original story

    11 hrs ago | Business Wire

    Vertex Energy, Inc. , an environmental services company that recycles industrial waste streams and off-specification commercial chemical products, announced today that it has begun due diligence of Heartland Group Holdings LLC under the terms of a letter of intent which contemplates Vertex acquiring substantially all of the assets of Heartland ... (more)

    Comment?

  4. Vertex Reports Second Quarter 2014 Financial Results and Provides...Read the original story

    Yesterday | Freshnews

    Vertex Pharmaceuticals Incorporated today reported consolidated financial results for the quarter ended June 30, 2014.

    Comment?

  5. Vertex SMB Announces Silver Sponsorship of Sage Summit 2014Read the original story

    Monday | PRWeb

    Vertex SMB, a leading sales and use tax solution provider for small and medium-sized business, today announced its silver sponsorship of the Sage Summit 2014, the annual event hosted by Sage North America, taking place July 28-31, 2014, at the Mandalay Bay in Las Vegas, Nevada.

    Comment?

  6. How will we pay for a $300,000 drug?Read the original story w/Photo

    Sunday Jul 27 | The Olympian

    Developed by Vertex Pharmaceuticals, it is the first drug that attacks not just the symptoms but the underlying cause of cystic fibrosis, a genetic lung disease that usually kills victims by the time they reach their 40s.

    Comment?

  7. Monday Deadline: Levi & Korsinsky, LLP Reminds Investors of Class...Read the original story w/Photo

    Friday Jul 25 | Business Wire

    Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of Massachusetts on behalf of investors who purchased Vertex Pharmaceuticals Incorporated securities between May 7, 2012 and May 29, 2012.

    Comment?

  8. Cystic Fibrosis Letdown ExplainedRead the original story w/Photo

    Thursday Jul 24 | Chemical & Engineering News

    ... to its proper place, and Kalydeco would then boost ion flow. Phase III clinical trial results support this idea. Vertex Pharmaceuticals, maker of Kalydeco, reported on June 24 that a combination of Kalydeco and its corrector molecule, lumacaftor, ...

    Comment?

  9. CIS Executive Breakfast Reengages AMP Final Rule and ACA PreparationRead the original story

    Wednesday Jul 23 | PressReleasePoint

    Industry experts from CIS and Vertex Pharmaceuticals will discuss their experiences preparing for the AMP Final Rule and other Affordable Care Act changes to date on July 29 in Boston.

    Comment?

  10. Cystic Fibrosis Drug Combination May Be Counteracting ItselfRead the original story w/Photo

    Wednesday Jul 23 | Chemical & Engineering News

    ... to its proper place, and Kalydeco would then boost ion flow. Phase III clinical trial results support this idea. Vertex Pharmaceuticals, maker of Kalydeco, reported on June 24 that a combination of Kalydeco and its corrector molecule, lumacaftor, ...

    Comment?

  11. Tests suggest limitations to Vertex's cystic fibrosis treatmentRead the original story w/Photo

    Wednesday Jul 23 | Boston.com

    Investors and patients were exuberant last month when Vertex Pharmaceuticals released results from clinical trials showing that cystic fibrosis patients' lung function improved on an experimental two-drug regimen.

    Comment?

  12. Investor Alert: Class Action Lawsuit Against Vertex Pharmaceuticals...Read the original story

    Wednesday Jul 23 | Customer Interaction Solutions

    ... for the District of Massachusetts on behalf of all purchasers of the common stock of Pharmaceuticals Incorporated ("Vertex" or the "Company") (NASDAQ:VRTX) between May 7, 2012 and May 29, 2012, inclusive (the "Class Period"). is engaged in ...

    Comment?

  13. Why it's so hard to develop a drug for cystic fibrosisRead the original story w/Photo

    Wednesday Jul 23 | Science

    ... gets to the cell surface like it's supposed to, but it's closed up tight and can't function. VX-770, designed by Vertex Pharmaceuticals, opens the protein into the right configuration so it can do its job. VX-770 was approved in 2012 for patients ...

    Comment?

  14. New cystic fibrosis drug shows great promiseRead the original story w/Photo

    Monday Jul 21 | Canada.com

    ... not revealed, the drug can cost up to $300,000 annually for patients in the United States. The drug was developed by Vertex Pharmaceuticals, which is headquartered in Boston. Kalydeco is among the first cystic fibrosis treatments to be released ...

    Comment?

  15. New cystic fibrosis drug shows great promiseRead the original story w/Photo

    Monday Jul 21 | Canada.com

    ... not revealed, the drug can cost up to $300,000 annually for patients in the United States. The drug was developed by Vertex Pharmaceuticals, which is headquartered in Boston. Kalydeco is among the first cystic fibrosis treatments to be released ...

    Comment?

  16. Codexis: $25m GSK tech accord could be catalyst for more Big Pharma dealsRead the original story w/Photo

    Tuesday Jul 15 | In-PharmaTechnologist.com

    ... . Previously, Codexis has cited hepatitis C as a key driver both as a result of the Merck deal and its work with Vertex Pharmaceuticals ( page 15 ). However, changing market dynamics mean this is no longer the case according to Nicols. " The ...

    Comment?

  17. New cystic fibrosis drug working for Greenwood manRead the original story w/Photo

    Saturday Jul 19 | The Chronicle Herald

    ... a year. Vallillee, a longtime fundraiser and advocate for cystic fibrosis patients, was approved last spring by Vertex Pharmaceuticals of Boston, the drug manufacturer, under its compassionate care program. "Things are incredible,'' he said in an ...

    Comment?

  18. Fed: Beware of social media, biotech stocksRead the original story w/Photo

    Tuesday Jul 15 | WTVR Richmond

    ... pulled back, with the Nasdaq Composite - home to many biotech and social media stocks - shedding 1%. Just look at Vertex Pharmaceuticals, which dropped 2% on the Fed comments. This biotech stock carries a forward price-to-earnings (P/E) ratio of ...

    Comment?

  19. Vertex Pharmaceuticals (MA) To Announce Second Quarter 2014 Financial Results On July 29Read the original story

    Tuesday Jul 15 | BioSpace

    Vertex Pharmaceuticals Incorporated will report its second quarter 2014 financial results on Tuesday, July 29, 2014 after the financial markets close.

    Comment?

  20. Investor Alert: Glancy Binkow & Goldberg LLP Reminds Investors of the ...Read the original story

    Tuesday Jul 15 | Business Wire

    Glancy Binkow & Goldberg LLP reminds investors of Vertex Pharmaceuticals Incorporated that all purchasers of Vertex common stock between May 7, 2012 and May 29, 2012, inclusive have until July 28, 2014, to file a motion to be appointed as lead plaintiff in the shareholder lawsuit.

    Comment?